| Literature DB >> 35558890 |
Mario Frías1,2, Laia Casades-Martí3, María Á Risalde1,2,4, Pedro López-López1,2, Raúl Cuadrado-Matías3, Antonio Rivero-Juárez1,2, Antonio Rivero1,2, Francisco Ruiz-Fons3.
Abstract
An experimental infection approach was used to estimate the competence of the common mosquito, Culex pipiens, for hepatitis E virus replication and transmission, using an isolate of hepatitis E virus genotype 3 of human origin in varying infectious doses. The experimental approach was carried out in biosafety level 2 conditions on three batches of 120 Cx. pipiens females, each using an artificial feeding system containing the virus in aliquots of fresh avian blood. Mosquitoes from each batch were collected 1, 7, 14, and 21 days post-infection (dpi) and dissected. The proboscis was subjected to forced excretion of saliva to estimate potential virus transmission. HEV RNA presence in abdomen, thorax, and saliva samples was analyzed by PCR at the selected post-infection times. HEV RNA was detected in the abdomens of Cx. pipiens females collected 1 dpi in the two experimentally-infected batches, but not in the saliva or thorax. None of the samples collected 7-21 dpi were positive. Our results show that Cx. pipiens is not a competent vector for HEV, at least for zoonotic genotype 3.Entities:
Keywords: Culex; HEV; experimental infection; mosquito; vector competence
Year: 2022 PMID: 35558890 PMCID: PMC9090475 DOI: 10.3389/fvets.2022.874030
Source DB: PubMed Journal: Front Vet Sci ISSN: 2297-1769
Figure 1Homemade feeder used in this study.
Figure 2Experimental feeding set-up with constant flow of circulating water.
Figure 3Base of the feeder during experimental infection.
Figure 4Methodological and chronological design of the study.
Number of samples positive for HEV RNA at each point.
|
|
|
|
| |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
| |
| Experimental batch (B1) | 0/5 | 0/5 | 5/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
| Experimental batch (B2) | 0/5 | 0/5 | 5/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
| Control | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 | 0/5 |
Inoculum used with 16,660,319 UI/mL.
Inoculum used with 4,992,494 UI/mL.